Lutris updates

News & Announcements

Updates on our clinical programs, corporate milestones, and financing.

Lutris Pharma Presents Data From a Real-World Analysis of Skin Toxicity From EGFR Inhibitors - an Unmet Challenge, at the 2023 American Academy of Dermatology Annual Meeting